Recent trends in pediatric bacterial meningitis in Japan – A country where Haemophilus influenzae type b and Streptococcus pneumoniae conjugated vaccines have just been introduced

• Published in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy Vol. 20; no. 8; pp. 477 - 483
• Main Authors: Shinjoh, Masayoshi, Iwata, Satoshi, Yagihashi, Tatsuhiko, Sato, Yoshitake, Akita, Hironobu, Takahashi, Takao, Sunakawa, Keisuke
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Ltd 01.08.2014
• Subjects: Anti-Bacterial Agents - pharmacology; Bacterial Capsules; Bacterial meningitis; Children; Cross-Sectional Studies; Female; Haemophilus Infections - epidemiology; Haemophilus Infections - microbiology; Haemophilus influenzae type b - drug effects; Haemophilus influenzae type b - isolation & purification; Haemophilus Vaccines; Hematology, Oncology and Palliative Medicine; Heptavalent Pneumococcal Conjugate Vaccine; Hib; Hospitalization; Humans; Incidence; Infant; Infant, Newborn; Japan - epidemiology; Male; Meningitis, Bacterial - epidemiology; Meningitis, Bacterial - microbiology; PCV; Pneumococcal Vaccines; Risk Factors; Streptococcal Infections - epidemiology; Streptococcal Infections - microbiology; Streptococcus pneumoniae - drug effects; Streptococcus pneumoniae - isolation & purification; Japan; Hib; PCV; Bacterial meningitis; Children
• ISSN: 1341-321X; 1437-7780
• DOI: 10.1016/j.jiac.2014.04.007

Abstract To investigate the trends in incidence and the characteristics of bacterial meningitis in Japan where Haemophilus influenzae type b (Hib) vaccine and 7-valent pneumococcal conjugated vaccine (PCV7) were introduced in 2008 and 2010, respectively, which was 5–20 years after their introduction in western countries. The nationwide Japanese survey of pediatric and neonatal bacterial meningitis was performed in 2011 and 2012. We analyzed the epidemiological and clinical data, and compared the information obtained in the previous nationwide survey database. We also investigated the risk factors for disease outcome. In the 2011–2012 surveys, 357 patients were evaluated. H. influenzae , Streptococcus pneumoniae , Streptococcus agalactiae and Escherichia coli were the main organisms. The number of patients hospitalized with bacterial meningitis per 1000 admissions decreased from 1.31 in 2009 to 0.43 in 2012 ( p  < 0.001). The incidence of H. influenzae and S. pneumoniae meningitis also decreased from 0.66 to 0.08 ( p  < 0.001), and 0.30 to 0.06 ( p  < 0.001), respectively. Only 0–2 cases with Neisseria meningitidis were reported each year throughout 2001–2012. The median patient age was 10–12 months in 2001–2011, and became lower in 2012 (2 month old) ( p  < 0.001). The fatality rate for S. agalactiae is the highest (5.9% (11/187)) throughout 2001–2012 among the four organisms. Risk factors for death and sequelae were convulsions at onset, low CSF glucose, S. agalactiae etiology, and persistent positive CSF culture. Hib vaccine and PCV7 decreased the rate of bacterial meningitis. Earlier introduction of these vaccines may have prevented bacterial meningitis among Japanese children.